- Home
- Software Solutions
- Resources
- Corporate
Intercept Pharmaceuticals
Intercept Pharmaceuticals Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Liver Cirrhosis, Biliary | >INT-747 | Phase_II | Study of INT 747 in Combi... | NCT00550862 |
| Active | Liver Cirrhosis, Biliary | >INT-747 | Phase_II | Study of INT-747 as Monot... | NCT00570765 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Diabetes Mellitus, Type II Fatty Liver | >INT-747 | Phase_II | Study of INT-747 in Patie... | NCT00501592 |